Serina Therapeutics SER
NYSE SER
$1.78 +0.01 (+0.56%)
As of: Oct 22, 2026 · 2:35 PM EDT

Serina Therapeutics (SER) Convertible Debt (2023 - 2026)

Updated

Serina Therapeutics' Convertible Debt came in at $3.09 million for Q2 2026.

Analysis

Serina Therapeutics (SER) Convertible Debt (2023 - 2026) Analysis & Trends

At the end of FY2025, Serina Therapeutics' Convertible Debt was $2.95 million.

  • Going back by year, Convertible Debt was $2.98 million in FY2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn
10 Serina Therapeutics 29.17 Mn -11.58 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 3.09 Mn
Dec 31, 2025 2.95 Mn
Dec 31, 2023 2.98 Mn
API Access

Serina Therapeutics Convertible Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=convertible-debt&ticker=SER&period=max&api_key=YOUR_API_KEY